F15.981
Other stimulant use, unspecified with stimulant-induced sexual dysfunction
Clinical Classification Guidelines
Inclusion Terms
- Amphetamine or other stimulant-induced sexual dysfunction, without use disorder
Medical Intelligence & Overview
ICD-10 Code F15.981 pertains to cases where an individual experiences sexual dysfunction caused by the use of stimulants, such as amphetamines or similar substances. This diagnosis is assigned when the sexual issues are directly linked to stimulant intake but without an accompanying stimulant use disorder, indicating that the person is not dependent on or addicted to the substance. Recognizing this condition helps health professionals address the sexual health concerns related to stimulant use and guide appropriate management strategies.
Causes & Symptoms
Clinical Causes: Use of stimulant substances like amphetamines, methamphetamines, or other similar drugs Temporary changes in the brain's chemistry affecting sexual function Physiological effects of stimulants, such as increased blood pressure or hormone changes Psychological effects, including increased anxiety or mood alterations caused by stimulant intake
Key Symptoms: Decreased libido or loss of sexual desire Difficulty achieving or maintaining an erection (erectile dysfunction) Problems with arousal or orgasm Reduced sexual satisfaction Persistent sexual dysfunction following recent stimulant use
Diagnostic & Treatment
Diagnosis Path: Diagnosing stimulant-induced sexual dysfunction involves a detailed medical history, including recent stimulant use, and a physical examination. Healthcare providers may inquire about the timing of stimulant consumption and sexual problems, ruling out other causes such as psychological issues or underlying medical conditions. Laboratory tests or screenings might be conducted to evaluate overall health and identify other contributing factors. The absence of signs of a stimulant use disorder distinguishes this diagnosis from a substance dependence condition.
Treatment Protocols: Discontinuing or reducing stimulant intake under medical supervision Counseling or behavioral therapy to address psychological aspects Sexual health counseling to improve intimacy and sexual performance Use of medications or other interventions targeted at specific sexual issues, if appropriate Monitoring and follow-up to assess symptom resolution after stopping stimulant use
Clinical Advice & FAQs
Billing Guidance
Is F15.981 a billable ICD-10 code?
Yes, F15.981 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.981?
Clinical documentation must specify the nature of Other stimulant use, unspecified with stimulant-induced sexual dysfunction and any associated comorbidities for accurate reporting.
Cite this Clinical Reference